0.05-0.2 mg/day; or clonidine, 0.1-0.3 mg twice daily) or an open-label step 3 agent (hydralazine, 25-100 mg twice daily) could be added. In addition, a number of ALLHAT participants (n=10,337 ...

During the eight-week treatment phase, patients received either moxonidine (0.2 or 0.4 mg/day) or the ACE inhibitor ... acting antihypertensives such as clonidine is widely acknowledged but ...

A decision is anticipated in the coming weeks. If approved, Eylea 8 mg would become the only anti-VEGF therapy in the EU offering treatment intervals of up to six months for both nAMD and DME.

The SGLT2 inhibitor empagliflozin (Jardiance) reduced the risk of creatinine increases and acute kidney injury (AKI) even in ...

Gotion's Gemstone all-solid-state battery has been loaded into vehicles and tested on the road. Several Chinese EV battery makers are aiming to start small-scale production of all-solid-state ...

A multi-agent tool that generates comprehensive company research reports. The platform uses a pipeline of AI agents to gather, curate, and synthesize information about any company.